Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.
Engel NW, Steinfeld I, Ryan D, Anupindi K, Kim S, Wellhausen N, Chen L, Wilkins K, Baker DJ, Rommel PC, Jarocha D, Gohil M, Zhang Q, Milone MC, Fraietta JA, Davis M, Young RM, June CH.
Engel NW, et al. Among authors: wellhausen n.
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2427216122. doi: 10.1073/pnas.2427216122. Epub 2025 May 5.
Proc Natl Acad Sci U S A. 2025.
PMID: 40324075